At a Glance:

The ‘Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium was officially convened in July 2023 between the non-profit Health and Environmental Sciences Institute (HESI) and the Broad Institute of Harvard and MIT. The Consortium is supported by an award from the Massachusetts Life Sciences Center (MLSC), in synergy with partnered resources and expertise from industry partners and in-kind contributions from academic, government, NGO, and biotech partners. This exciting effort engages >60 global experts in toxicology, cell biology, bioinformatics, risk assessment, and assay development from more from 15 academic institutes, 7 government agencies, 17 industry organizations, and 4 non-government organizations.